Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Rebound for Cannabis stocks in 2022 ???
View:
Post by 1hot-techwoman on Jan 03, 2022 7:37am

Rebound for Cannabis stocks in 2022 ???

https://apple.news/ARViaFWcaQXqrs-CEBzGm8Q
Comment by anjz661 on Jan 03, 2022 9:16pm
I don't know about a rebound per se, but some consolidation in the sector would make alot of sense.  Good to be sitting on a pile of cash for LABS.
Comment by alleyesonme on Jan 04, 2022 12:06am
Democrats use legalization to entice younger voters.... They cannot string voters along any longer because Republicans are now onside with this so politically they must deliver by midterms....if not and Republicans win.... pass legislation and deliver a big blow to democrats for not getting this done...Labs being hybrid, recreational/Pharma deserves a premium.... FDA recently approved epidiolex ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities